Interestingly, more primitive MM cell progenitors (e.g., CD138−,CD19+, CD20+,CD27+) [35] were at least, if not more, sensitive to this regimen than their more mature counterparts. The gene discussed is CD19; the disease is Miyoshi myopathy.